Biswas Fellows advance early-stage ideas at the frontiers of health and life sciences Five early-career researchers have been named Biswas Fellows, joining a growing cohort supported by the MIT Health and Life Sciences Collaborative (HEALS) to pursue bold, interdisciplinary research with the potential to improve human health. Match Day 2026: How Harvard Medical School Students Chose Their Specialty Awaiting residency placements, graduates share excitement about chosen fields. New sensor sniffs out pneumonia on a patient’s breath The technology could enable fast, point-of-care diagnoses for pneumonia and other lung conditions. MIT-Royalty Pharma Faculty Founder Initiative supports biotech innovators Offering substantial prize funding alongside workshops, classes, and mentorship, the initiative helps translate early-stage biotech research into venture-ready innovation. Injectable “satellite livers” could offer an alternative to liver transplantation The engineered tissue grafts could take on the liver’s function and help thousands of people with liver failure. Pagination First page « First Previous page Previous Page 1 Current page 2 Page 3 Page 4 Page 5 Page 6 Page 7 … Next page Next Last page Last »
Biswas Fellows advance early-stage ideas at the frontiers of health and life sciences Five early-career researchers have been named Biswas Fellows, joining a growing cohort supported by the MIT Health and Life Sciences Collaborative (HEALS) to pursue bold, interdisciplinary research with the potential to improve human health.
Match Day 2026: How Harvard Medical School Students Chose Their Specialty Awaiting residency placements, graduates share excitement about chosen fields.
New sensor sniffs out pneumonia on a patient’s breath The technology could enable fast, point-of-care diagnoses for pneumonia and other lung conditions.
MIT-Royalty Pharma Faculty Founder Initiative supports biotech innovators Offering substantial prize funding alongside workshops, classes, and mentorship, the initiative helps translate early-stage biotech research into venture-ready innovation.
Injectable “satellite livers” could offer an alternative to liver transplantation The engineered tissue grafts could take on the liver’s function and help thousands of people with liver failure.
